CompletedNot Applicable

Ultrasound Guided Femoral Nerve Block

United States44 participantsStarted 2015-08

Plain-language summary

The goal of the study is to evaluate whether pain control achieved by Ultrasound Guided Femoral Nerve Blockade (USFNB) is equal in efficacy to standard pain management practice of parenteral injection of opioid pain medication in patients presenting to the emergency department (ED) with hip fracture.

Who can participate

Age range18 Years – 101 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients over 18 years of age presenting to the ED with radiographically established intra-, extracapsular hip fracture, able to consent and participate in the study and who have moderate to severe pain (numerical pain score \>= 31) at the time of enrollment. Exclusion Criteria: * Patients with a previous history of hypersensitivity to local anesthetics, * Patients who have signs of a local infection at the site of planned needle placement. * INR \> 1.4NOAC use within 48 hours * Prophylactic Low-Molecular Weight Heparin (LMWH) within 12 hours * Therapeutic LMWH within 24 hours * Prophylactic Unfractionated Heparin (5000 Units BID or TID) within 6 hours

What they're measuring

pain intensity reduction

Timeframe: 4 hours after initiation of study proceduure

Trial details

NCT IDNCT02381717

SponsorBeth Israel Deaconess Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05

View on ClinicalTrials.gov More Hip Fracture trials